Pimavanserin a Better Option for Parkinson’s Psychosis?

Pimavanserin a Better Option for Parkinson’s Psychosis?

Publication date: Oct 11, 2024

If it [quetiapine] works, it works the next day or the day after, whereas with pimavanserin you have to wait for a week or two. “Our general impression in the United States is that pimavanserin has a slower uptake in efficacy as compared with quetiapine. So that’s why an additional drug this one has a slightly different mechanism is incredibly helpful in the clinic because not everyone responds to quetiapine. There was one unrelated fatal stroke in the quetiapine group. “Katzenschlager pointed out that pimavanserin is not approved in Europe and that the present study was conducted for regulatory purposes in India. Mane is an employee of Sun Pharma Laboratories. Katzenschlager reported having no relevant financial relationships. “We did discuss this with most of our investigators, and they gave the same reason.

Concepts Keywords
01treatment Day
Austria Days
Hospitalization Drug
Nighttime Drugs
Efficacy
Group
Improvement
Mane
Mean
Parkinson
Pimavanserin
Psychosis
Quetiapine
Said
Sleep

Semantics

Type Source Name
disease MESH Neurodegenerative Disorders
disease MESH stroke
disease MESH nasopharyngitis
disease MESH delusions
disease MESH hallucinations
disease MESH Movement Disorders
disease MESH dementia
disease MESH cognitive impairment
disease MESH drooling
disease MESH agranulocytosis
drug DRUGBANK Clozapine
disease MESH Parkinson’s disease
drug DRUGBANK Quetiapine
disease MESH Psychosis
drug DRUGBANK Tropicamide
drug DRUGBANK Pimavanserin

Original Article

(Visited 2 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *